Berberine in combination with anti-PD-L1 suppresses hepatocellular carcinoma progression and metastasis via Erk signaling pathway
Our study proposed that the combination treatment of BBR and anti-PD-L1 markedly inhibited the tumorigenesis of HCC by Erk signaling pathway. We hope our research can provide a new strategy for the potential of BBR as a therapeutic agent in the treatment of HCC.
Authors
- Dongxiao Xiang
- Xingwei Gu
- Ganggang Miao
- Hongyong Cao (ORCID: https://orcid.org/0000-0003-1188-991X)
- Zhiyu Zhang (ORCID: https://orcid.org/0000-0001-8992-1647)
- Meiyan Wang
Institutions
- Nantong University (CN)
- Affiliated Hospital of Nantong University (CN)
- Second Affiliated Hospital of Nanjing Medical University (CN)
- Suzhou Industrial Park Institute of Services Outsourcing (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Annals of Medicine and Surgery
- Published
- 2024-12-11
- DOI
- https://doi.org/10.1097/ms9.0000000000002746
- Citations
- 1
- Primary Topic
- Berberine and alkaloids research
- Type
- article
- Field-Weighted Citation Impact
- 0.45